Spesifik Enfeksiyonlarda Konservatif Tedavi

Sternbach G. Percivall Pott: tuberculous spondylitis. J Emerg Med. 1996 Jan-Feb;14(1):79-83. doi: 10.1016/0736-4679(95)02053-5. PMID: 8655942.

Pott P. The chirurgical works of Percivall Pott, F.R.S., surgeon to St. Bartholomew's Hospital, a new edition, with his last corrections. 1808. Clin Orthop Relat Res. 2002 May;(398):4-10.

Papa V, Varotto E, Vaccarezza M, Galassi FM. Morphologic and Clinical Aspects of Pott Disease in Ancient Human Remains: A Scoping Review. Spine (Phila Pa 1976). 2025 Feb 15;50(4):E56-E69

Alavi SM, Sharifi M. Tuberculous spondylitis: risk factors and clinical/paraclinical aspects in the south west of Iran. J Infect Public Health. 2010;3:196–200.

Garg RK, Somvanshi DS. Spinal tuberculosis: a review. J Spinal Cord Med. 2011;34:440–454.

Kerner G, Ramirez-Alejo N, Seeleuthner Y, et al. Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry. Proc Natl Acad Sci U S A. 2019;116:10430–10434.

Kerner G, Laval G, Patin E, et al. Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years. Am J Hum Genet. 2021;108:517–524.

Banik S, Madavi S. Navigating Perioperative Challenges in Pott's Spine: A Comprehensive Review. Cureus. 2024 May 8;16(5):e59871.

Rajasekaran S, Soundararajan DC, Shetty AP, Kanna RM. Spinal tuberculosis: current concepts. Global Spine J. 2018;8:96–108.

Leowattana W, Leowattana P, Leowattana T. Tuberculosis of the spine. World J Orthop. 2023;14:275–293.

Ahmed N, Khan MSI, Ahsan MK, Ahmed N, Khan MSI, Ahsan MK. Pott’s paraplegia. Edited by Seyed Mansoor Rayegani, London: IntechOpen; 2022. (https://www.intechopen.com/chapters/84160)

Oguz E, Sehirlioglu A, Altinmakas M, Ozturk C, Komurcu M, Solakoglu C, et al. A new classification and guide for surgical treatment of spinal tuberculosis. International Orthopaedics. 2008;32(1):127-133

Borcak D, Yeşilbağ Z. Pott hastalığı (tüberküloz spondilodiskiti). Şenbayrak S, editör. Kemik ve Eklem Enfeksiyonları. 1. Baskı. Ankara: Türkiye Klinikleri; 2024. p.39-45.

Dhouibi J, Kalai A, Chaabeni A, Aissa A, Ben Salah Frih Z, Jellad A. Rehabilitation management of patients with spinal tuberculosis (Review). Med Int (Lond). 2024 Apr 4;4(3):28.

Canetti G, Debeyre J, Seze SD. Sterilization of lesions in osteoarticular tu berculosis by antibacillary chemotherapy. Rev Tuberc (Paris)1957;21:1337- 44

T.C. Sağlık Bakanlığı. Tüberküloz Tanı ve Tedavi Rehberi, 2. Baskı, Ankara 2019. T.C. Sağlık Bakanlığı Yayın No: 1129. 33

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147-e195

Blumberg HM, Leonard MK Jr, Jasmer RM Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA. 2005;293(22):2776.

World Health Organization WHO consolidated guidelines on drug-resistant tuberculosis treatment http://www.ncbi.nlm.nih.gov/books/NBK539517/ (2019), Accessed Feb 2025

Internal Clinical Guidelines Team (UK). Tuberculosis: Prevention, Diagnosis, Management and Service Organisation. London: National Institute for Health and Care Excellence (UK); 2016.

Kandwal P, G V, Jayaswal A. Management of Tuberculous Infection of the Spine. Asian Spine J. 2016 Aug;10(4):792-800.

Garg D, Goyal V. Spinal Tuberculosis Treatment: An Enduring Bone of Contention. Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):441-448.

Sekhar Sethy S, Mittal S, Goyal N, Sudhakar PV, Verma V, Jain A, Verma A, Vathulya M, Sarkar B, Kandwal P. Healing Assessment of Spinal Tuberculosis: A Systematic Review. World Neurosurg. 2024 May;185:141-148.

MRC Working Party on Tuberculosis of the Spine; Darbyshire J. Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine. Int Orthop. 1999;23(2):73-81.

Soundararajan DCR, Rajasekaran RB, Rajasekaran S, Shetty AP, Kanna RM. Drug-resistant spinal tuberculosis - Current concepts, challenges, and controversies. J Clin Orthop Trauma. 2020 Sep-Oct;11(5):863-870.

Rafailidis PI, Avramopoulos I, Sapkas G, Falagas ME. Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates. J Infect. 2006 Feb;52(2):e35-7.

Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009 Sep 9;4(9):e6914.

Jain AK, Dhammi IK, Modi P, Kumar J, Sreenivasan R, Saini NS. Tuberculosis spine: Therapeutically refractory disease. Indian J Orthop. 2012 Mar;46(2):171-8.

29. Jutte PC , Van Loenhout-Rooyackers JH. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev2006; 1:CD004532.

30. Nene A , Bhojraj S. Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J2005; 5:79–84.

Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ. 2016 Dec;115(6):317-21. PMID: 29094869.

Kim JH, Ahn JY, Jeong SJ, Ku NS, Choi JY, Kim YK, Yeom JS, Song YG. Prognostic factors for unfavourable outcomes of patients with spinal tuberculosis in a country with an intermediate tuberculosis burden: a multicentre cohort study. Bone Joint J. 2019 Dec;101-B(12):1542-1549

Dunn RN, Ben Husien M. Spinal tuberculosis: review of current management. Bone Joint J. 2018 Apr 1;100-B(4):425-431.

Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR. Executive Summary: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis. 2015 Sep 15;61(6):859-63

Gu Z, Yang Z, Fei L, Wei D, Ma L, Liu Q, Shi J. Quantifying research hotspots and trends in brucella spondylitis: a bibliometric analysis. Front Surg. 2025 Jan 7;11:1465319.

Tali ET, Koc AM, Oner AY. Spinal brucellosis. Neuroimaging Clin N Am. 2015 May;25(2):233-45.

Jeyaraman N, Jeyaraman M, Nallakumarasamy A, K S, Adhikari S, Rijal R, Asija A, Sedhai YR, Sah S, Mohanty A, Bonilla-Aldana DK, Sah R. A proposed management classification for spinal brucellosis from India. Travel Med Infect Dis. 2023 Jul-Aug;54:102614.

Yagupsky P, Morata P, Colmenero JD. Laboratory Diagnosis of Human Brucellosis. Clin Microbiol Rev. 2019 Nov 13;33(1):e00073-19

Aktar F, Tekin R, Bektaş MS, Güneş A, Köşker M, Ertuğrul S, Yılmaz K, Karaman K, Balık H, Yolbaş İ. Diagnostic role of inflammatory markers in pediatric Brucella arthritis. Ital J Pediatr. 2016 Jan 11;42:3.

Spernovasilis N, Karantanas A, Markaki I, Konsoula A, Ntontis Z, et al. Brucella Spondylitis: Current Knowledge and Recent Advances. J Clin Med. 2024 Jan 19;13(2):595.

Ulu-Kilic A, Karakas A, Erdem H, Turker T, Inal AS, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2014 Feb;20(2):O75-82.

Unuvar GK, Kilic AU, Doganay M. Current therapeutic strategy in osteoarticular brucellosis. North Clin Istanb. 2019 Oct 24;6(4):415-420.

Bayindir Y, Sonmez E, Aladag A, Buyukberber N. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. J Chemother. 2003 Oct;15(5):466-71.

Alp E, Koc RK, Durak AC, Yildiz O, Aygen B, Sumerkan B, Doganay M. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect Dis. 2006 Apr 11;6:72.

Yang XM, Jia YL, Zhang Y, Zhang PN, Yao Y, et al. Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis. Drug Des Devel Ther. 2021 Nov 23;15:4733-4740.

Zou X, Li X, He K, Song Q, Yin R. Current knowledge of vertebral osteomyelitis: a review. Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):213-231

Sundaram VK, Doshi A. Infections of the spine: a review of clinical and imaging findings undefined. The Journal of Practical Imaging and Management 2016; 45: 10-20.

Williams RL, Fukui MB, Meltzer CC, Swarnkar A, Johnson DW, Welch W. Fungal spinal osteomyelitis in the immunocompromised patient: MR findings in three cases. AJNR Am J Neuroradiol 1999; 20: 381-5.

Bariteau JT, Waryasz GR, McDonnell M, Fischer SA, Hayda RA, Born CT. Fungal osteomyelitis and septic arthritis. J Am Acad Orthop Surg. 2014 Jun;22(6):390-401.

Asperges E, Albi G, Truffelli F, Salvaderi A, Puci F, Sangani A, Zuccaro V, Scotti V, Orsolini P, Brunetti E, Bruno R. Fungal Osteomyelitis: A Systematic Review of Reported Cases. Microorganisms. 2023 Jul 17;11(7):1828.

Yu LD, Feng ZY, Wang XW, Ling ZH, Lin XJ. Fungal spondylodiscitis in a patient recovered from H7N9 virus infection: a case study and a literature review of the differences between Candida and Aspergillus spondylodiscitis. J Zhejiang Univ Sci B. 2016 Nov.;17(11):874-881

Gamaletsou MN, Rammaert B, Brause B, Bueno MA, Dadwal SS, et al.; International Consortium for Osteoarticular Mycoses. Osteoarticular Mycoses. Clin Microbiol Rev. 2022 Dec 21;35(4):e0008619.

Perna A, Ricciardi L, Fantoni M, Taccari F, Torelli R, Santagada DA, Fumo C, Tamburrelli FC, Proietti L. Spontaneous Vertebral Aspergillosis, the State of Art: A Systematic Literature Review. Neurospine. 2021 Mar;18(1):23-33.

Skaf GS, Kanafani ZA, Araj GF, Kanj SS (2010) Non-Pyogenic Infections of the Spine. Int J Antimicrob Agents 36:99–105.

Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1-50.

Thompson GR, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M et al (2023) Rezafungin versus Caspofungin for Treatment of Candidaemia and Invasive Candidiasis (ReSTORE): A Multicentre, Double-Blind, Double-Dummy, Randomised Phase 3 Trial. Lancet 401:49–59.